Alira Health的动态

Catch up on this essential presentation by Julian Strange from the 13th Edition of Complete Revascularization https://ow.ly/Khra50RyEsy With reference to real-world cases, this presentation touches on three key points: ??lesion assessment ??preparation ??stent deployment This video serves as a valuable guide for HCPs facing the complexities of managing Aorto-ostial disease in clinical practice.

? Only a few hours remain till our final webinar! Register now if you haven't done so already: https://lnkd.in/epKv9knb? The webinar will explore the skills required in implementing a step?wise approach for patients with or at risk of developing?#cardiovascular?disease, recognising the risk and understanding the management of?#hyperkalaemia, and discussing the latest recommendations for additional risk-based therapies in?#CKD. #KidneyHealthforAll?#ChronicKidneyDisease?#CVD KDIGO

T-2 days to go. ?? Clinicians, we’re only halfway through the tick season ??, you sure don’t want to miss our upcoming webinar "Navigating the Complexities of Lyme Disease: Challenges and Controversies" on Friday, July 12th at 1:00pm EST. Our distinguished panel members will discuss controversies, diagnosis, treatment challenges, common misconceptions and best practices to confidently manage Lyme disease cases. Limited spots, register now: https://bit.ly/3z9bWtt #LymeDisease #epocrates #Webinar #WebinarAlert

?????????????? ??????????????????. ???????? ???????? ?????????????? ????????????????. ?????????????? ?????? Rare disease patients face complex challenges in navigating the care pathway. Clarivate's point-of-care messaging helps ?????????????????? support HCPs in delivering optimal care to rare disease patients who are lost in the system by providing real-time, targeted information. DM for more information. #RareDisease #Biopharma #PatientCare

What steps do you take to reduce the burden for your patients with retinal disease who receive bilateral anti-VEGF injections? ? Listen to this episode of ‘A Chat with Anat’, where Professor Anat Loewenstein?leads a practical discussion about how these patients can be supported. Barometer and Vision Academy member, Professor Paul Mitchell, is joined by Vision Academy member, Associate Professor Alex Hunyor, for this engaging episode. ? Explore more episodes of ‘A Chat with Anat’ on Spotify?or Apple, to hear Anat discuss other key topics with internationally renowned experts on how to enhance care and optimize treatment for patients with retinal disease. ? The Vision Academy Viewpoint that discusses the impact of bilateral treatment outcomes and provides recommendations to minimize the resulting burden can be found here https://lnkd.in/eBQXZgv. ? #ExpandKnowledge #Awareness #VisionAcademy

?????????????? ?????? ???? ???????? ???????? ?????????????? ???????????????? ???????? ?????????????? patients often struggle to find the right treatment path. Clarivate's point-of-care messaging can bridge this gap by helping HCPs identify ???????? ?????????????? ???????????????? to accelerate their diagnosis and care journey. DM for more information. #RareDisease #POCMessaging

Be sure to download our 2024 Glaucoma Report by Eyes On Eyecare! This report reflects the opinions of nearly 400 optometrists across diverse professional backgrounds and practice settings. Utilizing a mixed-methods approach—combining quantitative and qualitative data through structured and open-ended questions—the 2024 Glaucoma Report explores prevalence, preparedness, preferences in disease diagnostics and management, confidence in treatment, feelings surrounding co-management, and more. Click below to read —and download the report—to garner insight into the challenges eyecare professionals are facing with glaucoma and the innovative ways they are choosing to overcome them. bit.ly/45LXHHs

Given the challenges of running rare disease trials, there are countless considerations to improve clinical program success. ?? We ran a poll to find what you consider the biggest challenge is when planning or running a rare disease trial. 52% of people identified 'subject recruitment/retention' as the most significant hurdle. Discover how Veristat can help you plan and execute strategies for a successful rare disease clinical trial ?? https://bit.ly/49BUUkI #RareDiseaseMonth #RareDiseases #RareDiseaseTrial

Innovative diagnostic tools are reshaping our approach to Sj?gren disease, a condition often overlooked in patient care. A promising pilot study showcases a noninvasive eye test that accurately detects meibomian gland dysfunction, potentially expediting diagnosis and treatment. As healthcare marketers, we must highlight the significance of this development and encourage collaboration among specialists to enhance patient outcomes. Embracing evidence-based strategies can drive impactful conversations in healthcare!

Your safety is our top priority. On World Patient Safety Day, we're spotlighting the vital role clinical trials play in enhancing diagnostic accuracy and timeliness. Our research helps identify biomarkers and risk factors for earlier diagnoses, and careful monitoring often uncovers previously undiagnosed conditions. The data we gather improves understanding of disease progression and refines diagnostic tools. With a focus on personalized medicine and error prevention, we’re committed to the slogan "Get it right, make it safe!" Explore how we're making a difference at aimtrials.com. ?? #worldpatientsafetyday #getitrightmakeitsafe #clinicalresearch #clinicaltrials #dfw #aimtrials